HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation.

Abstract
Alveolar macrophages (AMs) undergo increased apoptosis during sepsis-induced acute respiratory distress syndrome (ARDS). Ghrelin exhibits an antiapoptotic effect in several cell types and protects against sepsis-induced ARDS in rats; however, the molecular mechanisms underlying this antiapoptotic effect remain poorly understood. In this study, we first examined the antiapoptotic effect of ghrelin on lipopolysaccharide (LPS)-stimulated AMs in vitro. In AMs, GH secretagogue receptor-1a (GHSR-1a), the ghrelin receptor, was expressed, and treatment of AMs with ghrelin markedly reduced LPS-induced apoptosis, mitochondrial transmembrane potential decrease, and cytochrome c release. These effects of ghrelin were mediated by GHSR-1a because a GHSR-1a-targeting small interfering RNA abolished the antiapoptotic action of ghrelin. LPS treatment activated the c-Jun N-terminal kinase (JNK) signaling pathway but inhibited the Wnt/β-catenin pathway. Interestingly, combined LPS-ghrelin treatment reduced JNK activation and increased Wnt/β-catenin activation. Furthermore, like ghrelin treatment, the addition of the JNK inhibitor SP600125 or the glycogen synthase kinase-3β inhibitor SB216763 rescued AMs from apoptosis. We also demonstrated that ghrelin altered the balance of Bcl-2-family proteins and inhibited caspase-3 activity. Next, we investigated whether ghrelin protected against septic ARDS in vivo. Sepsis was induced in male rats by performing cecal ligation and puncture; administration of ghrelin reduced sepsis-induced AMs apoptosis, pulmonary injury, protein concentrations in the bronchoalveolar lavage fluid, the lung neutrophil infiltration, and wet to dry weight ratio. However, administration of a specific ghrelin-receptor antagonist, [D-Lys-3]-GH-releasing peptide-6, abolished the beneficial effects of ghrelin. Collectively our results suggest that ghrelin exerts an antiapoptotic effect on AMs at least partly by inhibiting JNK and activating the Wnt/β-catenin pathway and thereby helps alleviate septic ARDS in rats.
AuthorsBin Li, Mian Zeng, Wanmei He, Xubin Huang, Liang Luo, Hongwu Zhang, David Y B Deng
JournalEndocrinology (Endocrinology) Vol. 156 Issue 1 Pg. 203-17 (Jan 2015) ISSN: 1945-7170 [Electronic] United States
PMID25337654 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ghrelin
  • Lipopolysaccharides
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Ghrelin
  • Wnt Proteins
  • bcl-2-Associated X Protein
  • beta Catenin
  • Peroxidase
  • JNK Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Apoptosis (drug effects, physiology)
  • Cell Line
  • Cell Survival
  • Ghrelin (pharmacology)
  • Inflammation (drug therapy)
  • JNK Mitogen-Activated Protein Kinases (genetics, metabolism)
  • Lipopolysaccharides (toxicity)
  • Lung Diseases (drug therapy)
  • Macrophages, Alveolar (drug effects)
  • Male
  • Peroxidase (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
  • RNA Interference
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Ghrelin (metabolism)
  • Signal Transduction (physiology)
  • Wnt Proteins (genetics, metabolism)
  • bcl-2-Associated X Protein (genetics, metabolism)
  • beta Catenin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: